Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$85.9M | 4.8 | (1,229.2%) | (1,239.3%) | (883.2%) | (55.7%) | (61.0%) | 12.5% | N/A | |
$402.0B | 6.1 | 35.5% | 28.0% | 24.3% | 76.5% | 46.8% | (1.0%) | 2.2% | |
$125.5B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$74.0B | 6.2 | 25.0% | 17.4% | 24.6% | 13.7% | 10.3% | 1.4% | 4.3% | |
$38.1B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$31.3B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$27.1B | 5.2 | (41.4%) | (48.4%) | 37.5% | (1.7%) | (5.5%) | (0.8%) | 0.0% | |
$14.8B | 4.9 | (12.7%) | (20.5%) | 13.4% | 1.0% | (6.1%) | (14.1%) | 13.6% | |
$14.6B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$14.0B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.2% | |
$1,846.9M | 4.3 | (38.4%) | (45.1%) | (41.5%) | (25.3%) | (24.7%) | 0.0% | 0.0% |
The Cabaletta Bio, Inc. (CABA) ROIC is (1,229.2%), compared to the industry median of ((123.1%)) and the 5-year historical average of 4,874.4%.
The Cabaletta Bio, Inc. (CABA) ROIC minus WACC is (1,239.3%), compared to the industry median of ((129.8%)) and the 5-year historical average of 4,864.9%.
The Cabaletta Bio, Inc. (CABA) ROE is (55.7%), compared to the industry median of ((51.8%)) and the 5-year historical average of (38.9%).
The Cabaletta Bio, Inc. (CABA) ROCE is (61.0%), compared to the industry median of ((51.0%)) and the 5-year historical average of (39.1%).